Workflow
Tobacco
icon
Search documents
3 Must-Buy U.S. Corporate Behemoths Despite Recent Volatility
ZACKS· 2025-05-15 13:06
Market Overview - Wall Street has experienced significant volatility over the past two months due to sticky inflation, weak economic data, and the imposition of reciprocal tariffs by the Trump administration, raising concerns about a potential near-term recession in the U.S. economy. All three major stock indexes are currently in negative territory year to date [1]. Investment Opportunities - Three U.S. corporate giants with a market capitalization of nearly $100 billion or more and a favorable Zacks Rank have provided positive returns in the past month. These companies are Amphenol Corp. (APH), AppLovin Corp. (APP), and Philip Morris International Inc. (PM), all holding a Zacks Rank 1 (Strong Buy) [2]. Amphenol Corp. (APH) - Amphenol provides connectivity solutions utilizing AI and machine learning technologies, offering high-density, high-speed connectors and cables optimized for signal integrity and thermal performance [4]. - The company benefits from a diversified business model, with strong demand across Commercial Air, Industrial, and Mobile devices, alongside defense technologies driving top-line growth [5]. - Amphenol's expected revenue and earnings growth rates for the current year are 30% and 38.6%, respectively, with the Zacks Consensus Estimate for current-year earnings improving by 12.9% in the last 30 days [6]. AppLovin Corp. (APP) - AppLovin operates a software-based platform for mobile app developers, enhancing marketing and monetization capabilities both domestically and internationally [7]. - The introduction of AI-powered AXON 2.0 technology and strategic expansion in gaming studios have significantly boosted revenue growth, while the Ai-enabled Audience+ marketing platform enhances reach into direct-to-consumer and e-commerce sectors [8]. - AppLovin's expected revenue and earnings growth rates for the current year are 24.3% and 70.6%, respectively, with the Zacks Consensus Estimate for current-year earnings improving by 13.7% in the last seven days [10]. Philip Morris International Inc. (PM) - Philip Morris has shown strong pricing power and an expanding smoke-free product portfolio, making significant progress in its smoke-free transition with products like IQOS and ZYN [11]. - The company anticipates robust growth in 2025, driven by increasing demand across all product categories, with an expected volume growth of 2% and smoke-free products projected to expand by 12-14% [12]. - Philip Morris's expected revenue and earnings growth rates for the current year are 8.1% and 13.7%, respectively, with the Zacks Consensus Estimate for current-year earnings improving by 4.2% over the last 30 days [13].
Is Altria's Post Q1 Earnings Stock Dip a Green Light for Investors?
ZACKS· 2025-05-13 14:35
Core Viewpoint - Altria Group Inc. experienced a 2.1% decline in share price following the release of its first-quarter 2025 results, contrasting with slight gains in the broader market and its industry peers [1][6]. Financial Performance - Altria reported first-quarter adjusted earnings per share (EPS) of $1.23, exceeding the Zacks Consensus Estimate of $1.17, reflecting a 6% year-over-year growth [6]. - Net revenues fell by 5.7% to $5.26 billion, primarily due to weaker cigarette shipment volumes [6][9]. - The Zacks Consensus Estimate for Altria's EPS for 2025 and 2026 has increased by 0.8% and 1.1%, respectively, indicating a positive outlook [12]. Market Comparison - Among tobacco peers, Turning Point Brands, Inc. outperformed with a 17.9% return, while Philip Morris International and British American Tobacco saw declines of 2.5% and 3.3%, respectively [2]. - Altria's forward 12-month price-to-earnings (P/E) ratio is 10.51x, significantly lower than the industry average of 14.55x and the S&P 500's average of 20.70x, suggesting it is undervalued [15][16]. Business Segments - Altria's Smokeable Products segment faced revenue softness due to declining shipment volumes, but robust pricing strategies helped mitigate margin erosion [8][9]. - The oral nicotine pouch brand on! saw an 18% increase in shipment volumes, reaching over 39 million cans, and expanded its market share in the nicotine pouch segment to 17.9% [10]. - The e-vapor segment faced challenges with the discontinuation of NJOY ACE, resulting in a non-cash impairment charge of $873 million, but the company remains committed to innovation in this space [11]. Investor Sentiment - The divergence between solid earnings performance and stock price weakness raises questions about whether the pullback is a short-term overreaction or a long-term buying opportunity [7]. - Altria's defensive business model and attractive valuation make it a stable investment option, especially for value-focused investors [19].
22nd Century (XXII) - 2025 Q1 - Earnings Call Transcript
2025-05-13 13:02
Financial Data and Key Metrics Changes - Net revenue for Q1 2025 was $6 million, a 50% increase sequentially from $4 million in Q4 2024 [28] - Gross margin showed a loss of $600,000, which is an improvement of 50% from the prior quarter [28] - Net loss from continuing operations improved to $3.3 million from $4.2 million in the preceding quarter [31] - Adjusted EBITDA loss improved to $2.3 million from $3.9 million in Q4 2024 [31] Business Line Data and Key Metrics Changes - Total cartons sold were 476,000, an increase of 41% compared to 338,000 in Q4 2024 [29] - The company is focusing on two main segments: reduced nicotine premium products and value-focused CMO brands [10][12] Market Data and Key Metrics Changes - The combustible cigarette market is valued at $85 billion, facing increasing price pressures and regulatory challenges [6] - The company aims to serve the Tier four market, which is approximately two-thirds the price of Tier one brands [10] Company Strategy and Development Direction - The company is transitioning into a growth model, focusing on expanding distribution and launching targeted marketing campaigns [12][20] - New product introductions include Smoker Friendly Black Label and VLN branded products, aimed at capturing market share in the natural cigarette and low nicotine segments [14][15] - The company is not waiting for FDA regulations to finalize its strategy and has developed technology for low nicotine tobacco products [22][23] Management's Comments on Operating Environment and Future Outlook - Management believes the current market dynamics present opportunities for high-quality branded products due to price pressures from big tobacco [21] - The company is on track to achieve breakeven EBITDA by Q4 2025, with expectations of revenue growth and margin improvement [25][35] Other Important Information - The company reduced its outstanding debt to $3.9 million, with debt-for-equity conversions of $3.1 million during the quarter [31] - A capital raise through warrant inducement raised approximately $5.4 million, providing cash runway for growth initiatives [32] Q&A Session Summary Question: Do you still foresee a breakeven of EBITDA for the fourth quarter of this year? - Yes, the company is on track to achieve breakeven in the latter half of the year [35] Question: Will CMO continue to grow from its first quarter level and will VLN kick in over the course of the year? - Yes, both Smoker Friendly and Pinnacle franchises are on a growth path, and state approvals for VLN will enhance distribution [36][37] Question: Does the increase in accounts receivable indicate a need for additional financial capital? - The company is comfortable with its cash runway after recent financing and the increase in receivables is due to new customer agreements [38][39] Question: What is the expected collection period for the accounts receivable balance? - The collection terms are typical for shipments, generally collected upon product delivery [40] Question: What has been the share issuance dilution from the warrants? - Current shares outstanding include approximately 7 million shares issued under the recent warrant inducement offering [42] Question: Are there any implications for twenty second Century Group from competitors' earnings results? - The company sees opportunities in the value segment due to price increases in the market and is anticipating the launch of partner VLNs [46][47] Question: Have we seen the worst of it in 2024, and are we now on a growth trajectory? - Yes, the company is now on a growth trajectory in terms of cartons, price, and revenue [48]
22nd Century (XXII) - 2025 Q1 - Earnings Call Transcript
2025-05-13 13:00
Financial Data and Key Metrics Changes - Net revenue for Q1 2025 was $6 million, a 50% increase sequentially from $4 million in Q4 2024 [28] - Gross margin loss improved by 50% to a loss of $600,000 from the previous quarter [28] - Net loss from continuing operations improved to $3.3 million from $4.2 million in the preceding quarter [31] - Adjusted EBITDA loss significantly improved to $2.3 million from $3.9 million in Q4 2024 [31] Business Line Data and Key Metrics Changes - Total cartons sold were 476,000, an increase of 41% compared to 338,000 in Q4 2024 [29] - The company is focusing on two main segments: reduced nicotine premium products and value-focused CMO brands [9][10] Market Data and Key Metrics Changes - The combustible cigarette market is valued at $85 billion, facing increasing price pressures and regulatory scrutiny [6] - The company aims to serve consumers transitioning from high nicotine products to lower nicotine options, capitalizing on market dynamics [21] Company Strategy and Development Direction - The company is transitioning into a growth phase, focusing on expanding distribution and launching targeted marketing campaigns [12][20] - New product introductions include Smoker Friendly Black Label and additional SKUs for existing brands, aimed at increasing market share [14][15] - The company is not waiting for FDA regulations to finalize its strategy and has developed technology for low nicotine products already approved by the FDA [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about achieving breakeven EBITDA by Q4 2025, supported by improved pricing structures and volume growth [34][36] - The company is focused on restoring fiscal responsibility and improving balance sheet ratios through debt reduction and working capital improvements [27] Other Important Information - The company has reduced its outstanding debt to $3.9 million and executed a capital raise of approximately $5.4 million [31][32] - A lawsuit against Dorchester Insurance Company for $9 million in business interruption insurance is ongoing, with a trial date set for November 2025 [32] Q&A Session Summary Question: Do you still foresee a breakeven of EBITDA for the fourth quarter of this year? - Management confirmed they are on track to achieve breakeven in the latter half of the year [34] Question: Will CMO continue to grow from its first quarter level and will VLN kick in over the course of the year? - Management indicated that both Smoker Friendly and Pinnacle franchises are on a growth path, with state approvals expected to drive distribution [36] Question: Does the increase in accounts receivable indicate a need for additional financial capital? - Management stated they are comfortable with their cash runway following recent financing and attributed the increase in receivables to new customer agreements [38][39] Question: What is the expected timeline for collecting the accounts receivable balance? - Management noted that collections occur upon product delivery, following typical shipment terms [40] Question: What has been the share issuance dilution from the warrants? - Current shares outstanding include approximately 7 million shares issued under the recent warrant inducement offering, with additional warrants expected to be exercised [42] Question: Are there any implications for twenty second Century Group from competitors' earnings results? - Management highlighted that trends in the market, particularly the migration from Tier one to Tier four brands, present opportunities for the company [46][48] Question: Have we seen the worst of it in 2024 past, and are we now on a growth trajectory? - Management confirmed that they are now on a growth trajectory in terms of cartons, price, and revenue [49]
22nd Century Group Reports First Quarter 2025 Financial Results
Globenewswire· 2025-05-13 10:00
Core Insights - 22nd Century Group, Inc. reported a significant sequential sales increase of approximately 50% in Q1 2025, driven by its growth strategy and new sales activities across various product categories [1][3][6] - The company is preparing for the launch of its first VLN partner brand shipments and has made regulatory filings for new products in all 50 states [1][6] - The financial results indicate a reduction in operating loss and net loss compared to the previous quarter, reflecting improved operational efficiency [6][10] Financial Performance - Net revenues for Q1 2025 reached $6.0 million, up from $4.0 million in Q4 2024, marking a 50% increase [6][10] - Gross profit improved to a loss of $(0.6) million from $(1.3) million, while operating expenses decreased to $2.0 million from $2.8 million [6][10] - The operating loss decreased to $(2.6) million from $(4.1) million, and net loss decreased to $(3.3) million from $(4.2) million [6][10] Product Developments - The company launched VLN Red, expanding its reduced nicotine content product line, which already includes VLN Gold and Green [6][12] - New partner branded VLN products are set to be launched, supported by marketing campaigns to enhance sales volumes [3][6] - Shipments of conventional products under a new agreement with Smoker Friendly have commenced, including the launch of Smoker Friendly Black Label cigarettes [6][12] Debt and Liquidity - As of the end of Q1 2025, the company reported net debt of $3.4 million, down from $4.6 million at the end of the previous quarter [6][12] - The company has successfully reduced its total debt by $3.7 million year-to-date while managing working capital needs [12][33]
Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2025
Prnewswire· 2025-05-12 11:00
Core Insights - Ispire Technology Inc. reported a decrease in accounts receivable from $67.7 million to $60.4 million, indicating an improvement in the company's financial position [1][3] - The company launched the SproutTM cannabis vapor device in collaboration with Raw Garden, emphasizing purity and safety [1][2] - Ispire is transitioning manufacturing to Malaysia, which is expected to reduce operating expenses by $8 million annually [2] Financial Performance - Revenue for the third quarter of fiscal 2025 was $26.2 million, down 12.7% from $30.0 million in the same period last year [4][5] - Gross profit decreased to $4.8 million with a gross margin of 18.2%, compared to $6.1 million and 20.4% respectively in the prior year [5][6] - Total operating expenses rose to $15.4 million from $11.8 million year-over-year [8] Loss and Cash Position - The net loss for the third quarter was $10.9 million, compared to a net loss of $5.9 million in the same quarter of the previous year [9][18] - As of March 31, 2025, the company held cash and cash equivalents of $23.5 million, with a working capital deficit of $2.1 million [9][16] Strategic Developments - Ispire received an interim license for manufacturing nicotine products in Malaysia, with expectations for a final license soon [2] - The company filed a PMTA with the FDA for IKE Tech's age-gating technology, which could be a significant milestone in age verification for vaping products [2][3]
Berkshire Hathaway Is a Great Bear Market Stock. These 2 Are Even Better Buys.
The Motley Fool· 2025-05-10 23:32
Group 1: Berkshire Hathaway and Warren Buffett - Warren Buffett, after 60 years of leadership, announced that Greg Abel will become CEO of Berkshire Hathaway by the end of the year [1] - Buffett has significantly outperformed the S&P 500, essentially doubling its annual return over his career [2] - Berkshire Hathaway is known for its stability and has outperformed the S&P 500 during recent market volatility [5] Group 2: Altria - Altria has a strong historical performance, particularly in down markets, and is currently the domestic seller of Marlboro and other cigarette brands [8] - The company benefits from a recession-resistant business model, with a high-yield dividend and a record of raising dividends 59 times in the last 55 years [9] - Altria's stock is up 16.6% this year, outperforming both Berkshire and the S&P 500, and has shown resilience during past bear markets [10][12] Group 3: AutoZone - AutoZone operates in the aftermarket auto parts sector, which tends to perform well during recessions as consumers prioritize repairs over new vehicle purchases [17] - The stock is up 17.8% year to date and has historically thrived during bear markets, gaining 22% during the financial crisis [18][19] - AutoZone has a pattern of accelerating sales towards the end of recessions, indicating strong potential for future performance [21][23] Group 4: Investment Considerations - Despite a recent 5% decline in Berkshire stock following Buffett's retirement announcement, the company remains a strong long-term investment due to its cash reserves of nearly $350 billion [24] - Investors looking to capitalize on potential bear markets may find Altria and AutoZone to be more attractive options based on their historical performance and business models [25]
22nd Century Group Completes Sale of Needle Rock Farms Assets
Globenewswire· 2025-05-08 21:07
Core Insights - 22nd Century Group, Inc. has successfully closed the sale of its Needle Rock Farms assets, generating net proceeds of approximately $770,000 after expenses, which will enhance its cash position [1][2] - The sale of these unused assets, previously related to the hemp cannabis business, allows the company to redeploy capital into its growth strategies for 2025, which are already showing positive results [2] - The company plans to report its complete first quarter results on May 13, 2025, along with a conference call on the same day [2] Company Overview - 22nd Century Group is a pioneering company in nicotine harm reduction within the tobacco industry, focusing on enabling smokers to control their nicotine consumption [3] - The flagship product, VLN cigarettes, contains 95% less nicotine than traditional cigarettes and has been proven to significantly reduce nicotine consumption [4] - The company operates a 60,000 square foot manufacturing facility in Mocksville, North Carolina, with the capacity to produce over 45 million cartons of combusted tobacco products annually [5] Technology and Innovation - The proprietary reduced nicotine tobacco blends are developed using patented technologies that regulate nicotine biosynthesis in the tobacco plant, ensuring full flavor and high yield with significantly lower nicotine content [6] - The extensive patent portfolio positions the company as the sole provider of low nicotine combustible cigarettes in the United States and key international markets [6]
PM Stock Up 6.9% Post Q1 Earnings: A Green Light for Investors?
ZACKS· 2025-05-08 16:45
Core Viewpoint - Philip Morris International Inc. has seen a significant stock increase of 6.9% following its first-quarter 2025 results, indicating renewed investor confidence in its long-term strategy, particularly in smoke-free products [1]. Group 1: Stock Performance - Philip Morris shares reached an all-time high of $176.49 on May 7, closing at $175.36, trading above both 50-day and 200-day moving averages, which is a bullish technical indicator [4]. - Over the past month, Philip Morris stock delivered a strong return of 15.5%, outperforming the broader market and industry peers, with the Zacks Tobacco industry rising 12.2% and the S&P 500 gaining 2.8% [7]. Group 2: Q1 Performance Highlights - In Q1 2025, Philip Morris reported revenues of $9.3 billion, a 5.8% increase year-over-year, with adjusted earnings per share (EPS) of $1.69, reflecting a 12.7% increase from the previous year [9]. - Revenues from smoke-free products surged 15% year-over-year, now accounting for 42% of total revenues, with IQOS leading the inhalable category and ZYN gaining traction in the oral nicotine segment [10]. Group 3: Future Outlook - The company anticipates total volume growth of 2% for 2025, with smoke-free products projected to grow 12-14%, indicating a strong shift towards reduced-risk alternatives [11]. - Management forecasts net revenue growth of 6-8% on an organic basis for 2025, with adjusted EPS expected to be between $7.36 and $7.49, marking a notable upward revision from previous estimates [13]. Group 4: Earnings Estimates - The Zacks Consensus Estimate for Philip Morris' 2025 and 2026 EPS has increased by 4.6% and 5.7%, respectively, indicating a bullish outlook for the stock [14]. - The consensus estimates imply 8.1% and 13.7% year-over-year growth for sales and EPS in 2025, respectively [14]. Group 5: Valuation Insights - Philip Morris is trading at a forward P/E ratio of 22.56, higher than the industry average of 15.04, reflecting investor confidence in its long-term growth strategy [17]. - This premium valuation indicates that investors are willing to pay more for companies innovating in reduced-risk product categories, positioning Philip Morris as a growth-oriented player in the tobacco sector [18].
Dividend Harvesting Portfolio Week 218: $21,800 Allocated, $2,195.04 In Projected Dividends
Seeking Alpha· 2025-05-08 13:00
Group 1 - The focus is on growth and dividend income as a strategy for retirement planning [1] - The portfolio is structured to generate monthly dividend income that grows through reinvestment and annual increases [1] Group 2 - The article expresses personal opinions and is not intended as investment advice [2][3] - It emphasizes the importance of conducting personal research before making investment decisions [2]